Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. (ALNAQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
alnaq · pe ratio · data through Dec 31, 2021
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Allena Pharmaceuticals, Inc. (ALNAQ) measures how much investors pay for each dollar of the company's trailing earnings. ALNAQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2021-12-31
PE Ratio History
2015 – 2021 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Allena Pharmaceuticals, Inc.You ALNAQ | $0M | N/A | — | -$1.03 |
 Primo Nutraceuticals Inc. BUGVF | $0M | N/A | — | -$0.88 |
 Green Hygienics Holdings Inc. GRYN | $0M | N/A | — | -$0.20 |
 IMV Inc. IMVIQ | $0M | N/A | — | -$4.55 |
 Indie Ranch Media, Inc. INDR | $0M | N/A | — | — |
 LifeHOUSE Holdings, LLC LHRP | $0M | N/A | — | — |
 Photoelectron Corp. PECN | $0M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2021-12-31Latest FY2021 | — | $-0.73 | — | |
2020-12-31 FY2020 | — | $-1.01 | — | |
2019-12-31 FY2019 | — | $-2.15 | — | |
2018-12-31 FY2018 | — | $-1.72 | — | |
2017-12-31 FY2017 | — | $-1.05 | — | |
2016-12-31 FY2016 | — | $-1.60 | — | |
2015-12-31 FY2015 | — | $-0.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Allena Pharmaceuticals, Inc. (ALNAQ) measures how much investors pay for each dollar of the company's trailing earnings. ALNAQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$1.03.
Frequently asked questions
ALNAQ pe ratio · 6 questionsALNAQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$1.03. Data sourced from Financial Modeling Prep via ALNAQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Allena Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09